EP2822531A2 - Suspension d'antitranspirant à vaporiser, à libération de principe actif améliorée et réduisant les salissures sur les textiles - Google Patents

Suspension d'antitranspirant à vaporiser, à libération de principe actif améliorée et réduisant les salissures sur les textiles

Info

Publication number
EP2822531A2
EP2822531A2 EP12808282.3A EP12808282A EP2822531A2 EP 2822531 A2 EP2822531 A2 EP 2822531A2 EP 12808282 A EP12808282 A EP 12808282A EP 2822531 A2 EP2822531 A2 EP 2822531A2
Authority
EP
European Patent Office
Prior art keywords
weight
composition
antiperspirant
composition according
aluminum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP12808282.3A
Other languages
German (de)
English (en)
Inventor
Bernhard Banowski
Nadine Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2822531A2 publication Critical patent/EP2822531A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Definitions

  • the present application relates to antiperspirant suspension sprays with improved release of active ingredient and reduced textile soiling.
  • Spray products are an indispensable part of modern everyday life. Numerous cosmetic products, such as hair sprays, deodorant sprays and oral sprays, allow a convenient, fast and uniform product application, which is highly appreciated by many consumers, thanks to the spray application.
  • a product form particularly popular with consumers are antiperspirant sprays. These contain an antiperspirant aluminum salt, which reacts relatively sour in contact with water. For this reason, hydrous antiperspirant sprays are more of a niche product, because the development of a stable, non-corrosive and effective formulation is not trivial. In contrast, anhydrous antiperspirant sprays enjoy great popularity in the market.
  • the antiperspirant aluminum salt which must be zirconium-free by law, is present in at least one liquid suspended under normal conditions.
  • At least one lipophilic thickener is added to this suspension as suspending aid, usually a hydrophobically modified phyllosilicate which is preferably selected from Disteardimonium Hectorite, Stearalkonium Hectorite, Stearalkonium Bentonite, Quaternium-18 Hectorite, Quaternium-18 Bentonite and Dihydrogenated Tallow Benzylmonium Hectorite ,
  • a hydrophobically modified phyllosilicate which is preferably selected from Disteardimonium Hectorite, Stearalkonium Hectorite, Stearalkonium Bentonite, Quaternium-18 Hectorite, Quaternium-18 Bentonite and Dihydrogenated Tallow Benzylmonium Hectorite .
  • this oil layer favors the spray pattern, that is, the active ingredient is not too much fogged, but reaches the skin specifically;
  • the oil layer provides some adhesion of the powdered antiperspirant active to the skin.
  • this oil layer may delay the release of the antiperspirant active into the effective water-soluble form.
  • less volatile oils contribute to a delay in drug release.
  • a high proportion of less volatile oils leads to poorly washable textile stains.
  • Cyclomethicone is already known in the art as a well-suited carrier oil for antiperspirant sprays. Since this oil has a relatively high volatility and thus does not block the antiperspirant active too strong, achieved with Cyclomethicone a very satisfactory release of Antitranspirantwirkstoffs and a relatively low Textilanschmutzung.
  • the use of cyclomethicones should be avoided as far as possible due to its persistence. It was therefore an object of the present application to formulate spray-free anhydrous antiperspirant compositions which, as far as possible, omit cyclomethicones which have improved release of the antiperspirant active ingredient and / or cause relatively little textile soiling.
  • the release of the antiperspirant active ingredient from an anhydrous antiperspirant composition can be improved and / or the textile soiling can be reduced if it comprises a relatively high proportion of volatile non-silicone oils, a relatively low proportion of non-volatile oils and 0 to less than 1 wt .-% cyclomethicone.
  • the present invention is therefore an antiperspirant composition for personal care in the form of a propellant sprayable or sprayable with a propellant suspension containing
  • compositions of the invention are substantially anhydrous, ie they contain 0 to at most 5 wt .-%, preferably 0.5 to 4.5 wt .-%, particularly preferably 1 to 4 wt .-%, most preferably 1, 5 to 3 Wt .-% free water, wherein also free water contents of 1, 6 - 2.4 wt .-%, 1, 7 - 2.3 wt .-% and 1, 8 - 2.2 wt .-% are preferred and where the amounts are based on the weight of the composition, without taking into account any existing propellant.
  • the content of water of crystallization, water of hydration or similar molecularly bound water which is contained in the constituents used, in particular in the antiperspirant active ingredients, does not constitute free water in the sense of the present application.
  • normal conditions are a temperature of 20 ° C. and a pressure of 1013.25 mbar. Melting point data likewise relate to a pressure of 1013.25 mbar.
  • compositions according to the invention are characterized in that the volatile isoparaffin is selected from isononane, isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, and isohexadecane, and mixtures thereof, preferably selected from isodecane, isoundecane, isododecane, isotridecane, and mixtures thereof.
  • the cosmetic oil is liquid under normal conditions. Under normal conditions liquid cosmetic oils are immiscible with water.
  • Essential oils according to the invention are understood to mean mixtures of volatile components which are prepared by steam distillation from vegetable raw materials, such as. B. citrus oils. As far as in the present application of a cosmetic oil is mentioned, this is always a cosmetic oil that is not a fragrance and no essential oil, is liquid under normal conditions and immiscible with water.
  • Ci 0 -Ci 3 -Isoparaffin mixtures in particular those having a vapor pressure at 20 ° C of 10 - 400 Pa, preferably 13 - 100 Pa.
  • the at least one volatile isoparaffin having a vapor pressure at 20 ° C. of 8 to 250 Pa is present in a total amount of> 18 to ⁇ 67.5% by weight, preferably> 30 to ⁇ 63% by weight, particularly preferably> 32, 4 - ⁇ 57.6 wt .-%, most preferably 40 - 55 wt .-%, each based on the total propellant-free composition.
  • compositions contain a C 10 -C 13 isoparaffin mixture having a vapor pressure at 20 ° C of 10 - 400 Pa in a total amount of> 18 to ⁇ 67.5 wt .-%, preferably> 30 - ⁇ 63 wt. -%, particularly preferably> 32.4 - ⁇ 57.6 wt .-%, most preferably 40 - 55 wt .-%, each based on the total propellant-free composition.
  • compositions preferred according to the invention are furthermore characterized in that the non-volatile ester oil having a vapor pressure at 20 ° C. of less than 2.62 Pa (0.02 mm Hg) is selected from esters of linear or branched saturated or unsaturated fatty alcohols with 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which may be hydroxylated, and the benzoic acid esters of linear or branched C 8 -22-alkanols, provided that they are liquid under normal conditions.
  • Preferred examples thereof are isopropyl palmitate, isopropyl stearate, isopropyl myristate, 2-hexyl decyl stearate, 2-hexyldecyl laurate, isononyl isononanoate, 2-ethylhexyl palmitate and 2-ethylhexyl stearate.
  • benzoic acid-Ci 2 -Ci 5 -alkyl esters for. B. available as a commercial product Finsolv ® TN (Ci 2 -Ci 5 -Alkylbenzoat), and isostearyl benzoate, z.
  • Finsolv ® SB 2-ethylhexyl
  • Finsolv ® EB benzoic acid 2-octyldocecylester
  • Finsolv ® BOD Another particularly preferred ester oil is triethyl citrate.
  • Extremely preferred ester oils are isopropyl myristate and 2-ethylhexyl palmitate.
  • the at least one non-volatile ester oil having a vapor pressure at 20.degree. C. of less than 2.66 Pa (0.02 mm Hg) is present in a total amount of> 3 to ⁇ 30% by weight, preferably> 5 to ⁇ 28% by weight .-%, more preferably> 5.4 - ⁇ 25.6 wt .-%, most preferably 10 - 20 wt .-%, each based on the total propellant-free composition.
  • Preferred antiperspirant aluminum salts are selected from the water-soluble astringent inorganic and organic salts of aluminum.
  • aluminosilicates and zeolites do not belong to the antiperspirant active ingredients, but may be involved as absorbent components in the reduction of perspiration.
  • water solubility is understood as meaning a solubility of at least 3% by weight at 20 ° C., that is to say amounts of at least 3 g of the antiperspirant active are soluble in 97 g of water at 20 ° C.
  • antiperspirant active ingredients are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al 2 (OH) 5 Cl. 1-6 H 2 O] n , preferably [Al 2 (OH) 5 Cl. 2-3 H 2 O. ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1-6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or in activated (depolymerized) form.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum glycol complexes, eg. Aluminum-propylene glycol complexes, aluminum sesquichlorohydrex-PG or aluminum sesquichlorohydrex-PEG, aluminum-PG-dichlorhydrex or aluminum-PEG-dichlorhydrex, aluminum hydroxide, further selected from potassium aluminum sulphate with zero to 12 parts water of crystallization (KAI (S0 4 ) 2 ⁇ 0H 2 0, KAI (S0 4 ) 2 ⁇ 1 H 2 0, KAI (S0 4 ) 2 ⁇ 2 H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0 , KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 )
  • antiperspirant active ingredients are selected from what are known as “activated” aluminum salts, which are also referred to as “antiperspirant active ingredients” having enhanced activity (English: enhanced activity).
  • activated aluminum salts are typically produced by heat treating a relatively dilute solution of the salt (e.g., about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio.
  • the activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • Activated aluminum salts typically have a HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks.
  • antiperspirant active substances are basic calcium aluminum salts, as disclosed, for example, in US Pat. No. 2,571,030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • antiperspirant active compounds are activated aluminum salts, as disclosed, for example, in US Pat. No. 6,245,325 or US Pat. No. 6,042,816, containing 5-78% by weight (USP) of an activated antiperspirant aluminum salt, an amino acid or hydroxyalkanoic acid in such an amount as to afford Amino acid or hydroxyalkanoic acid) to AI weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10, and a water-soluble calcium salt in such an amount to give a Ca: Al weight ratio of 1: 1-1: 28 and preferably 1: 2 - 1: 25 provide.
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US Pat. No. 6,245,325 or US Pat. No.
  • 6,042,816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4%. 13 wt .-% molecularly bound water (water of hydration), further sufficient water-soluble calcium salt that the Ca: Al weight ratio of 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid that the amino acid to Al - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4 - 13% by weight of molecularly bound water (water of hydration), furthermore as much water-soluble calcium salt, that the Ca: Al weight ratio is 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much glycine that the glycine to Al - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • an activated aluminum salt and 1-16% by weight preferably 4 - 13% by weight of molecularly bound water (water of hydration)
  • water of hydration molecularly bound water
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further so much water-soluble calcium salt that the Ca: AI weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and is so much hydroxyalkanoic that the hydroxyalkanoic acid to AI - Weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum salt, an amino acid or hydroxyalkanoic acid in such amount as to add (amino acid or hydroxyalkanoic acid) Al - weight ratio of 2: 1 - 1: 20 and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount to have a Sr: Al weight ratio of 1: 1 - 1:28 and preferably 1: 2 - 1: 25.
  • USP activated aluminum salts
  • an amino acid or hydroxyalkanoic acid in such amount as to add (amino acid or hydroxyalkanoic acid) Al - weight ratio of 2: 1 - 1: 20 and preferably 1: 1 to 1:10
  • a water-soluble strontium salt in such an amount to have a Sr: Al weight ratio of 1: 1 - 1:28 and preferably 1: 2 - 1: 25.
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4-13% by weight. -% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: Al weight ratio is 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid that the amino acid to AI - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • -% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: Al weight ratio is 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid that the amino acid to AI - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4-13% by weight .-% molecularly bound water, further so much water-soluble strontium salt that the Sr: Al weight ratio of 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and is so much glycine that the glycine to Al - weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4-13% by weight .-% molecularly bound water, further so much water-soluble strontium salt that the Sr: Al weight ratio of 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and is so much hydroxyalkanoic that the hydroxyalkanoic acid to Al - weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or N0 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2.1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a” is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2..1: 1 ,
  • Preferred aluminum salts have a molar metal-to-chloride ratio of 0.9-1.3, preferably 0.9-1.1, more preferably 0.9-1.0.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is contained in a total amount of> 25-40% by weight, preferably 26-35% by weight, based on the total weight of the water-free active substance (USP). in the total blowing agent-free composition.
  • USP water-free active substance
  • the composition contains a adstringie- rendes aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ® Ultrafine or Super Ultrafine from Reheis, Microdry 323 of Summit, as Chlorhydrol ® as well as in activated form as Reach ® sold by Reheis 501 , Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred. Particular preference is also activated aluminum chlorohydrates that are available under the names Reach ® 101 and Reach ® 103 Aach 7171 by Reheis or Summit are.
  • the antiperspirant active ingredients are suspended in a water-immiscible carrier, it is preferred for reasons of product stability that the active ingredient particles have a number average particle size of 0, 1 - 200 ⁇ , preferably 1 - 150 ⁇ , particularly preferably 3 - 100 ⁇ and extraordinarily preferably 5 - 80 ⁇ , have.
  • Preferred active ingredient particles have a volume-average particle size of 0.2-220 ⁇ m, preferably 3-160 ⁇ m, more preferably 4-125 ⁇ m, more preferably 5-12 ⁇ m, and most preferably 10-80 ⁇ m.
  • Preferred aluminum salts have a molar metal-to-chloride ratio of 1, 9 -2, 1, or for sesquichlorohydrate of 1, 5: 1-1, 8: 1 on.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in an amount of 27-38% by weight, preferably zugt 30 - 35 wt .-%, particularly preferably 32 - 34 wt .-%, is contained, based on the total weight of the water-free active substance (USP) in the blowing agent-free total composition.
  • USP water-free active substance
  • the composition contains an astringent aluminum salt, in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • an astringent aluminum salt in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • Preferred non-activated aluminum chlorohydrates for example, in powder form as Micro Dry ®, Micro Dry ® Ultrafine or Micro Dry ® -323 from Summit / Reheis, as Chlorhydrol ® (powder) as well as in activated form as Reach ® 101, Reach ® 103, Reach ® 501 from Reheis / Summit or AACH-7171 from Summit. Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is also particularly preferred.
  • compositions according to the invention are characterized in that disteardimonium hectorites and at least one polar activator selected from ethanol,> 0 to 5 wt .-% of water and propylene carbonate, are contained, wherein the wt .-% indication based on the weight of refers to the entire composition.
  • a further subject of the present application is an antiperspirant cosmetic product consisting of a composition according to claim 1, 2, 3, 4, 5, 6, 7 or 8, at least one propellant and an aerosol dispenser.
  • Propellants which are preferred according to the invention are selected from propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air , Oxygen, nitrous oxide, dichlorofluoromethane, chlorodifluoromethane, chlorofluoromethane, 1, 1, 2,2-tetrachloro-1-fluoroethane, 1, 1, 1, 2-tetrachloro-2-fluoroethane, 1, 2,2-trichloro-1, 1 -difluoro-ethane, 1, 1, 2-trichloro-1, 2-difluoroethane, 1, 1, 1-trichloro-2,2-difluoroethane, 2,2-dichloro-1,1,1-trifluoro-ethane, 1 , 2-dichloro-1,1,2-trifluoro-ethane
  • hydrophilic propellants such as carbon dioxide
  • hydrophilic gases such as carbon dioxide
  • lipo- phile propellant gas eg propane / butane
  • the amount of the blowing agent is preferably 5-95% by weight, more preferably 30-90% by weight and most preferably 60-86% by weight, and still more preferably 75-78% by weight, based in each case on the Total weight of the preparation consisting of the composition according to the invention and the propellant.
  • Containers of metal (aluminum, tinplate, tin), protected or non-splitterndem plastic or glass, which is externally coated with plastic in question, in their selection pressure and fracture resistance, corrosion resistance, easy Be Shellbar- ability such as also aesthetic aspects, handiness, printability etc. play a role.
  • Special internal protective lacquers ensure the corrosion resistance with respect to the suspension according to the invention.
  • An inner protective lacquer which is preferred according to the invention is an epoxy-phenolic lacquer, as it is known, inter alia. available under the name Hoba 7407 P.
  • the valves used on an internally painted valve disc wherein the coating and valve material are compatible with each other. If aluminum valves are used, their valve plates can be internally z. B.
  • compositions according to the invention are characterized in that at least one encapsulated active ingredient is contained.
  • the active compounds which may advantageously be encapsulated, are in particular fragrances and / or cooling agents, but also other skin care active substances, such as vitamins, antioxidants, etc.
  • Preferred capsule material are water-soluble polymers such as starch, physically modified and / or chemically modified starches, cellulose derivatives, such as. As carboxymethylcellulose, methylcellulose, hydroxyethylcellulose or hydroxypropylmethylcellulose, carragheenes, alginates, maltodextrins, dextrins, vegetable gums, pectins, xanthans, polyvinyl acetate and polyvinyl alcohol, polyvinylpyrrolidine, polyamides, polyesters and homopolymers and copolymers of monomers selected from acrylic acid, methacrylic acid , Maleic acid, fumaric acid, itaconic acid and the esters and the salts of these acids, as well as any mixtures of these polymers.
  • Preferred capsule materials are chemically modified starches, in particular aluminum starch octenylsuccinate, eg.
  • aluminum starch octenylsuccinate eg.
  • the commercial product Dry Flo Plus from National Starch
  • sodium starch octenylsuccinate eg.
  • the commercial product Capsul from National Starch further carboxymethylcellulose, carboxymethylcellulose, methylcellulose, hydroxyethylcellulose and hydroxypropylmethylcellulose, ethylcellulose, e.g.
  • the commercial product Tylose H 10 from Clariant continue Carragheene, alginates and maltodextrins, and any mixtures of these polymers.
  • compositions and products of the present invention show the optimum ratio of drug release of the antiperspirant aluminum salt, low greasy fabric scuff even after multiple wash cycles, high compatibility with other additives such as perfume capsules, deodorant capsules, and aqueous silver salt solutions.
  • the improvements ratings are also perceptible to the untrained consumer.
  • compositions according to the invention also contain at least one fragrance.
  • a fragrance in the sense of the present application is in accordance with the expert definition as it can be found in the R ⁇ MPP Chemie Lexikon, as of December 2007.
  • a fragrance is a chemical compound with odor and / or taste that excites the hair cell receptors of the olfactory system (adequate stimulus).
  • the physical and chemical properties required for this purpose are a low molecular weight of at most 300 g / mol, a high vapor pressure, minimal water and high lipid solubility and weak polarity, and the presence of at least one osmotic group in the molecule.
  • fragrances according to the invention have a molecular weight of 74 to 300 g / mol, contain at least one osmophoric group in the molecule and have a smell and / or taste, that is, they excite the receptors of the hair cells of the olfactory system.
  • perfumes perfumes, perfume oils or perfume oil ingredients can be used.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg.
  • ethers, aldehydes, ketones, alcohols and hydrocarbons e.g.
  • Fragrance compounds of the ester type are known e.g.
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g.
  • the linear alkanals of 8 - 18 C atoms citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones e.g.
  • the alcohols include anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and the terpineneols alpha-terpineol, beta-terpineol, gamma-terpineol and delta-terpineol.
  • the hydrocarbons include mainly the Terpenes like limes and pinas.
  • compositions of the invention contain at least one perfume in a total amount of 0.00001 to 10 wt .-%, preferably 0.5 to 7 wt .-%, most preferably 1-6 wt .-%, each based on the total weight of the composition ,
  • compositions contain at least one deodorant active ingredient in a total amount of 0.001 to 10 wt .-%, preferably 0.2 to 7 wt .-%, particularly preferably 1-5 wt .-%, most preferably 1, 5-3 % By weight, the weight percentages being based on the total weight of the composition.
  • ethanol does not count as a deodorant active ingredient, but, if present, only as a constituent of the carrier.
  • the compositions according to the invention contain as deodorising agent at least one silver salt, which is preferably selected from silver sulfate, silver nitrate, silver citrate, silver dihydrogen citrate, silver lactate, silver acetate, silver malate, silver succinate, silver tartrate, silver mandelate, silver salicylate, silver gluconate, silver adipate and silver nitrate. galactarate, as well as mixtures of these salts. Highly preferred are silver sulfate, silver citrate, silver dihydrogen citrate and silver lactate, as well as mixtures of these salts.
  • compositions according to the invention comprise at least one silver salt, which is preferably selected from silver sulfate, silver nitrate, silver citrate, silver dihydrogen citrate, silver lactate, silver acetate, silver malate, silver succinate, silver tartrate, silver mandelate, silver salicylate, silver gluconate, silver adipate and silver bergaractarate, as well as mixtures of these salts
  • silver salts which is preferably selected from silver sulfate, silver nitrate, silver citrate, silver dihydrogen citrate, silver lactate, silver acetate, silver malate, silver succinate, silver tartrate, silver mandelate, silver salicylate, silver gluconate, silver adipate and silver bergaractarate, as well as mixtures of these salts
  • compositions according to the invention contain as deodorising agent at least one aromatic alcohol of the structure (AA-1),
  • the radicals R to R 6 independently of one another represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, which may be linear or branched and substituted with OH groups or alkoxy groups having 1 to 5 carbon atoms,
  • radicals R 7 to R independently of one another are a hydrogen atom, a halogen atom, in particular a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, in particular with a methoxy group,
  • n, o, p are, independently of one another, integers from 0 to 10, where at least one of the values n, o, p ⁇ 0.
  • Particularly preferred products of the invention contain at least one alcohol AA-1, as described above, which is selected from anisalcohol, 2-methyl-5-phenyl-pentan-1-ol,
  • compositions according to the invention contain at least one alcohol AA-1, as described above, in a total amount of 0.05-10 wt.%, Preferably 0.1-5 wt.%, Particularly preferably 0.2-2 wt %, most preferably 0.3-1.5% by weight, based in each case on the weight of the composition.
  • Extremely preferred compositions according to the invention contain 2-benzylheptan-1-ol in a total amount of 0.05-1.5% by weight, preferably 0.1-1% by weight, particularly preferably 0.2-0.5% by weight. -%, in each case based on the weight of the composition.
  • the alcohols AA-1 may be contained in encapsulated form.
  • compositions according to the invention contain as deodorant active ingredient at least one 1,2-alkanediol having 5 to 12 C atoms, which is represented by the formula HO-CH 2 -CH (OH) - (CH 2 ) n -CH 3 in which n represents the numbers 2, 3, 4, 5, 6, 7, 8 or 9, and mixtures of these 1, 2-alkanediols.
  • 1, 2-alkanediols having 5 to 12 C atoms which are particularly preferred according to the invention are selected from 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol and mixtures thereof.
  • a very particularly preferred combination according to the invention are mixtures of 1, 2-hexanediol and 1, 2-octanediol, preferably in a weight ratio of 10: 1 to 1:10, more preferably from 5: 1 to 1: 5, particularly preferably in the weight ratio of 1: 1
  • Preferred compositions according to the invention contain at least one 1,2-alkanediol having 5 to 12 C atoms, which is described by the formula HO-CH 2 -CH (OH) - (CH 2 ) n -CH 3 , in which n represents the Numbers 2, 3, 4, 5, 6, 7, 8 or 9, in a total amount of 0.2 to 15 wt .-%, preferably 0.3 to 10 wt .-%, particularly preferably 0.4 -.
  • compositions according to the invention contain from 0.2 to 0.5% by weight of 1,2-hexanediol and from 0.2 to 0.5% by weight of 1,2-octanediol, based in each case on the weight of the composition.
  • compositions according to the invention are characterized by a content of the deodorant active ingredient 3- (2-ethylhexyloxy) -1,2-propanediol, preferably in one Total amount of 0.05-5 wt.%, Preferably 0.1-2 wt.%, Particularly preferably 0.2-1.5 wt.%, Most preferably 0.5-1.0 wt.% , in each case based on the weight of the composition.
  • compositions according to the invention are characterized by a content of tropolone (2-hydroxy-2,4,6-cycloheptatrienone), preferably in an amount of 0.001-0.1% by weight, based on the weight of the composition.
  • compositions according to the invention are characterized by a content of the deodorant active ingredient triethyl citrate.
  • Triethyl citrate is a known deodorant active, which acts as an enzyme inhibitor for esterases and lipases and thus contributes to the broadband effect of inventive compositions.
  • Preferred compositions according to the invention contain from 0.5 to 15% by weight, preferably from 3 to 8% by weight, most preferably from 4 to 6% by weight, based in each case on the weight of the composition.
  • compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme arylsulfatase.
  • Deodorant active ingredients which are preferred according to the invention and act as arylsulfatase inhibitors are those disclosed in US Pat. Nos. 5,643,559, 5,576,937, WO2001 / 099376 A2, EP 1430879 A1 and DE 10216368 A1.
  • compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme arylsulfatase, in a total amount of 0.001-10 wt.%, Preferably 0.01-5 wt.%, Particularly preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition.
  • compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme beta-glucuronidase.
  • Deodorant active ingredients which are active according to the invention and act as a beta-glucuronidase inhibitor are those disclosed in WO2003 / 039505 A2.
  • Further particularly preferred compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme beta-glucuronidase, in a total amount of 0.001-10 wt.%, Preferably 0.01-5 wt.%, More preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition.
  • compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme lipase.
  • preferred deodorant active ingredients which act as lipase inhibitor are selected from those disclosed in EP 1428520 A2, further selected from the aminomethylenemalonic acid derivatives according to DE 3018132 A1, the ethylene oxide-propylene oxide copolymers according to GB 2335596 A1 and the Salts of phytic acid according to EP 650 720 A1.
  • More special Preferred compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme lipase, in a total amount of 0.001-10 wt.%, preferably 0.01-5 wt.%, particularly preferably 0.1. 2.5 wt .-%, each based on the weight of the composition.
  • compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of 5-lipoxygenase.
  • Deodorant active ingredients which are preferred according to the invention and act as 5-lipoxygenase inhibitors are disclosed in EP 1428519 A2.
  • Further particularly preferred compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme 5-lipoxygenase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, more preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition.
  • compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme cystathionine beta-lyase.
  • Deodorant active ingredients which are preferred according to the invention and which act as inhibitors of cystathione beta-lyase are selected from those disclosed in EP 495918 B1, WO 2006/079934, DE 102010000746 A1, WO2010 / 031657 A1 and WO2010 / 046291 A1.
  • compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme cystathionine-beta-lyase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, particularly preferably 0.1-2.5% by weight, in each case based on the weight of the composition.
  • compositions according to the invention are characterized by a content of at least one cationic phospholipid of the formula KPL,
  • Preferred alkyl groups having 8 to 22 C atoms are selected from an n-octyl, n-nonyl, n-decyl, n-undecyl, lauryl, n-tridecanyl, myristyl, n-pentadecanyl, cetyl , Palmityl, stearyl, Elaidyl, arachidyl, behenyl and a cocyl group.
  • a representative cocyl group consists, based on their total weight, of 4-9% by weight of n-octyl, 4-9% by weight of n-decyl, 45-55% by weight of lauryl, 15-21 % By weight of myristyl, 8-13% by weight of palmityl and 7-14% by weight of stearyl groups.
  • Preferred alkenyl groups having 8 to 22 C atoms are selected from a linoleyl group ((9Z, 12Z) -Octadeca-9,12-dien-1-yl) and a linolenyl group ((9Z, 12Z, 15Z) octadeca - 9, 12, 15-trien-1-yl).
  • a preferred hydroxyalkyl group having 8 to 22 C atoms is selected from a 12-hydroxystearyl group.
  • compositions according to the invention contain as deodorant active ingredient a cationic phospholipid of the formula KPL,
  • at least one cationic phospholipid of the formula KPL having the abovementioned features in a total amount of 0.05-2% by weight is preferred 0, 1 - 1 wt .-%, particularly preferably 0, 15 - 0.4 wt .-%, each based on the weight of the composition.
  • compositions according to the invention comprise a cationic phospholipid of the formula KPL,
  • compositions according to the invention comprise a cationic phospholipid of the formula KPL,
  • R is a myristoylaminopropyl group
  • R 2 and R 3 are methyl groups
  • x 2
  • y 1
  • M is a sodium ion
  • compositions according to the invention comprise a cationic phospholipid of the formula KPL,
  • R is a lauroylaminopropyl group
  • R 2 and R 3 are methyl groups
  • x 2
  • y 1
  • M is a sodium ion
  • deodorant active ingredients are odor absorbers, deodorizing ion exchangers, germ-inhibiting active ingredients, prebiotic components and enzyme inhibitors or, particularly preferably, combinations of the active substances mentioned.
  • Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention.
  • the silicates which are particularly preferred according to the invention include, in particular, phyllosilicates and among these, in particular, montmorillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum.
  • odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably present in a total amount of 0.1 to 10% by weight, more preferably 0.5 to 7% by weight and most preferably 1 to 5% by weight, based in each case on the total composition.
  • germ-inhibiting or antimicrobial active ingredients are understood to mean those active substances which reduce the number of skin germs involved in the formation of odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci.
  • Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds. These include u. a. Triclosan, chlorhexidine and chlorhexidine gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride , Laurylisoquinolinium bromide, methylbenzethonium chloride.
  • phenol phenoxyethanol, di-sodium dihydroxyethylsulfosuccinyl undecylenate, sodium bicarbonate, zinc lactate, sodium phenol sulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as.
  • farnesol chlorophyllin copper complexes, and carboxylic acid esters of mono-, di- and triglycerol (eg Glyce- rinmonolaurat, diglycerol monocaprinate) preferred deodorant agents.
  • compositions according to the invention contain at least one deodorant active ingredient which is selected from silver salts, aromatic alcohols of structure AA-1 having the abovementioned substituents, 1,2-alkanediols having 5 to 12 carbon atoms, alpha- (2-ethylhexyl) glycerol ethers (3 - (2-Ethylhexlyoxy) -1, 2-propanediol), tropolone, triethyl citrate, cationic phospholipids of the formula KPL with the abovementioned substituents, and mixtures thereof.
  • deodorant active ingredient which is selected from silver salts, aromatic alcohols of structure AA-1 having the abovementioned substituents, 1,2-alkanediols having 5 to 12 carbon atoms, alpha- (2-ethylhexyl) glycerol ethers (3 - (2-Ethylhexlyoxy) -1, 2-propanediol), tropolone,
  • composition of some preferred suspensions according to the invention can be found in the following tables.
  • the quantities are, according to the wording of claim 1, always based on the total weight of the respective component in the composition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

La présente invention concerne des suspensions d'antitranspirant à vaporiser, à libération de principe actif améliorée et réduisant les salissures sur les textiles.
EP12808282.3A 2011-12-22 2012-12-05 Suspension d'antitranspirant à vaporiser, à libération de principe actif améliorée et réduisant les salissures sur les textiles Ceased EP2822531A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011089560A DE102011089560A1 (de) 2011-12-22 2011-12-22 Schweißhemmendes Suspensionsspray mit verbesserter Wirkstofffreisetzung und verringerter Textilanschmutzung
PCT/EP2012/074437 WO2013092208A2 (fr) 2011-12-22 2012-12-05 Suspension d'antitranspirant à vaporiser, à libération de principe actif améliorée et réduisant les salissures sur les textiles

Publications (1)

Publication Number Publication Date
EP2822531A2 true EP2822531A2 (fr) 2015-01-14

Family

ID=47458875

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12808282.3A Ceased EP2822531A2 (fr) 2011-12-22 2012-12-05 Suspension d'antitranspirant à vaporiser, à libération de principe actif améliorée et réduisant les salissures sur les textiles

Country Status (3)

Country Link
EP (1) EP2822531A2 (fr)
DE (1) DE102011089560A1 (fr)
WO (1) WO2013092208A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013220779A1 (de) * 2013-10-15 2015-04-16 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel mit Lactaten
DE102013225616A1 (de) * 2013-12-11 2015-06-11 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel mit Lysozym und/oder Bovine serum albumin und/oder Yoghurt Protein
AU2015202609B2 (en) * 2014-05-30 2019-08-01 Johnson & Johnson Consumer Companies, Inc. Aerosol deodorant antiperspirant compositions
DE102021200919A1 (de) 2021-02-02 2022-08-04 Beiersdorf Aktiengesellschaft Antitranspirantsprays mit geringerer Textilverfleckung

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
DE3018132A1 (de) 1980-05-12 1981-11-19 Henkel Kgaa Hautpflegemittel
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
MX173955B (es) 1989-10-10 1994-04-11 Gillette Co Composicion desodorante que contiene inhibidores de la enzima beta-liasa de aminoacidos
US5643559A (en) 1991-10-30 1997-07-01 Colgate-Palmolive Company Deodorant compositions comprising inhibitors of odor-producing axillary bacterial exoenzymes
EP0650720A1 (fr) 1993-10-28 1995-05-03 Sanwa Kagaku Kenkyusho Co., Ltd. Compositions pour le roin de la peau ou déodorant
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
GB2335596A (en) 1998-03-24 1999-09-29 Procter & Gamble Polyalkyleneglycol Copolymers as Lipase Inhibitors
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
WO2001099376A2 (fr) 2001-06-01 2001-12-27 Henkel Kommanditgesellschaft Auf Aktien Inhibiteurs d'arylsulfatase employes dans des deodorants et des agents anti-transpiration
DE10154368A1 (de) 2001-11-06 2003-05-15 Henkel Kgaa Beta-Glucuronidase-Inhibitoren in Deodorantien und Antitranspirantien
DE10216368A1 (de) 2002-04-12 2003-10-16 Henkel Kgaa Arylsulfatase-Inhibitoren in Deodorantien und Antitranspirantien
DE10257738A1 (de) 2002-12-10 2004-06-24 Henkel Kgaa 5-Lipoxigenase-Inhibitoren in Deodorantien und Antitranspirantien
DE10260954A1 (de) 2002-12-20 2004-07-01 Henkel Kgaa Arylsulfatase-Inhibitoren in Deodorantien und Antitranspirantien
US20040241200A1 (en) * 2003-05-19 2004-12-02 Daniel Winn Personal care products that do not contain tetramer and/or pentamer cyclomethicones
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
EP1846436B1 (fr) 2005-01-31 2012-09-12 Firmenich S.A. Inhibition des mauvaises odeurs de transpiration
DE102008047743A1 (de) 2008-09-17 2010-04-15 Henkel Ag & Co. Kgaa Verwendung von Harnstoff-Derivaten und Phenacylthiazolium-Salzen zur Behandlung von Körpergeruch
DE102008053034A1 (de) 2008-10-24 2010-04-29 Henkel Ag & Co. Kgaa Verwendung von Hydroxyzimtsäuren und ihren Derivaten und/oder von Pflanzenextrakten zur Behandlung von Körpergeruch
DE102009002098A1 (de) * 2009-04-01 2010-10-07 Henkel Ag & Co. Kgaa Wasserfreie Antitranspirant-Sprays mit verbesserter Wirkstofffreisetzung
DE102009002097A1 (de) * 2009-04-01 2010-10-07 Henkel Ag & Co. Kgaa Antitranspirant-Sprays mit Esterölen
DE102009029669A1 (de) * 2009-09-22 2011-03-24 Henkel Ag & Co. Kgaa Wasserfreie Antitranspirant-Sprays mit verbesserter Wirkstofffreisetzung
DE102010000746A1 (de) 2010-01-08 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von 1,2-Alkandiolen zur Behandlung von Körpergeruch

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2013092208A2 *

Also Published As

Publication number Publication date
DE102011089560A1 (de) 2013-06-27
WO2013092208A2 (fr) 2013-06-27
WO2013092208A3 (fr) 2014-12-11

Similar Documents

Publication Publication Date Title
EP2785309B1 (fr) Spray aérosol cosmétique à effet rafraîchissant durable
EP2827829B1 (fr) Émulsions huile dans l'eau d'antitranspirant sans peg présentant des propriétés haptiques améliorées
EP2934461B1 (fr) Sprays antitranspirants ménageant les textiles, contenant des acides hydroxycarboxyliques
WO2011029701A2 (fr) Compositions antibactériennes, cosmétiques ou dermatologiques appropriées à la désodorisation corporelle, destinées à lutter contre les odeurs corporelles
EP2451426A2 (fr) Compositions cosmétiques contenant des suspensions de sels d'argent
DE102015225958A1 (de) Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen
DE102011086019A1 (de) Deodorant- und Antitranspirant-Zusammensetzungen zur Verhinderung von Körpergeruch
DE102017201025A1 (de) "Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen"
DE102016205699A1 (de) Aerosolzusammensetzungen mit verbesserter Wirkstoffaufbringung
EP2822531A2 (fr) Suspension d'antitranspirant à vaporiser, à libération de principe actif améliorée et réduisant les salissures sur les textiles
EP2934465B1 (fr) Sprays antitranspirants ménageant les textiles, contenant de l'acide méthane-sulfonique
EP3057665A1 (fr) Agent cosmétique anti-transpiration contenant des lactates
DE102016221154A1 (de) Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen
DE102015225892A1 (de) Deodorantien, enthaltend spezielle cyclische Alkohole in Kombination mit bestimmten Deowirkstoffen
DE102015225876A1 (de) "Deodorantien, enthaltend spezielle kationische Morpholinoverbindungen in Kombination mit bestimmten Deowirkstoffen"
WO2013092114A2 (fr) Déodorants et antitranspirants contenant un antioxydant stabilisé
EP2782551A1 (fr) Compositions déodorantes
WO2014187576A1 (fr) Association de principes actifs désodorisante
EP3028744B1 (fr) Spray aerosol cosmetique ayant un effet de fraicheur
EP3057566A1 (fr) Agent cosmétique anti-transpirant contenant des acides polyphosphoriques
EP3057666A1 (fr) Agent cosmétique anti-transpiration contenant des acides sulfoniques aromatiques
WO2013092185A2 (fr) Anti-transpirants ménageant les textiles
DE102015225971A1 (de) Verfahren zur Reduzierung des durch die Transpiration ausgelösten Körpergeruchs unter Verwendung von speziellen Proteinhydrolysaten
US20200197277A1 (en) Cosmetic agents containing a combination of at least two different active ingredients
DE102011089610A1 (de) Verfahren zur Herstellung eines kosmetischen Produkts mit einer verdickten Ölphase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140306

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20151221

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20160708